, -
For type 2 diabetes , NICE guideline NG28 recommends GLP-1 receptor agonists in specific circumstances, including: As part of triple therapy (with metformin and either a sulfonylurea or pioglitazone) when dual therapy with metformin and another oral drug has not achieved adequate glycaemic control As part of triple therapy with metformin and a sodium-glucose cotransporter 2 (SGLT2) inhibitor if certain criteria are met In combination with insulin, with or without other antidiabetic drugs Treatment should be continued only if there is a beneficial metabolic response (reduction of at least 11 mmol/mol in HbA1c and weight loss of at least 3% at 6 months)
Choose bland, easily digestible foods during the nausea adjustment period: cooked vegetables, lean proteins, plain rice, oatmeal, bananas, and applesauce are excellent choices
Weight loss injections, particularly GLP-1 receptor agonists like Semaglutide (found in Ozempic and Wegovy) and Tirzepatide (used in Mounjaro), work by mimicking a natural hormone called GLP-1
Furthermore, Hu et al (42) discovered that the downregulation of the GPX3 gene resulted in a decrease in the wound healing capacity and transmembrane migration rate of OC and colorectal cancer cells
